Consistent with animal studies, immunoblotting analysis of liver tissues obtained from HCC patients indicated higher levels of PAK4, total-, phospho-, and nuclear-NCoR1, and lower levels of HMGCS2 in tumor compared to non-tumorous tissues (Fig. 7c and Supplementary Fig. 10c, d). The gene discussed is PAK4; the disease is hepatocellular carcinoma.